Albemarle Corporation

ALB Basic Materials Specialty Chemicals

Albemarle Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, down 4.37% from fiscal 2024. In the quarter to June 2026, revenue grew 31.1%, EPS grew 2,425.0%, free cash flow grew 708.4% and total debt fell 48.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

95.48 2.70 −2.75%
Market cap
$11.6B
P/E
199×
Fwd P/E
14.9×
Dividend yield
1.70%
F-score
6/9
Altman Z
2.31
Beneish M
−3.71
Dividend safety
47/100

Albemarle Corporation (ALB) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Sep 2, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits Officer departure
8-K Aug 19, 2026 5.02 Departure or appointment of directors or officers
10-Q Jun 30, 2026 P1I2: 18 added · 1 removed · 43 modified
P2I1A: 2 modified
8-K Aug 5, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 21, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jun 1, 2026 5.02 Departure or appointment of directors or officers
8-K May 5, 2026 5.02 Departure or appointment of directors or officers; 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K May 6, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 13, 2026 5.02 Departure or appointment of directors or officers
8-K Mar 19, 2026 1.01 Entry into a material definitive agreement; 9.01 Financial statements and exhibits
8-K Mar 2, 2026 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Feb 26, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 4 added · 3 removed · 24 modified
1A: 16 added · 23 removed · 75 modified
7: 30 added · 41 removed · 76 modified
8-K Feb 11, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Dec 8, 2025 5.02 Departure or appointment of directors or officers
10-Q Sep 30, 2025
8-K Nov 5, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 23, 2025 1.01 Entry into a material definitive agreement; 2.06 Material impairment; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits Impairment
10-Q Jun 30, 2025
10-K Dec 31, 2024

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.